作者
Stephan H Duda, Marc Bosiers, Johannes Lammer, Dierk Scheinert, Thomas Zeller, Vincent Oliva, Alexander Tielbeek, John Anderson, Benjamin Wiesinger, Gunnar Tepe, Alexandra Lansky, Michael R Jaff, Catharina Mudde, Hans Tielemans, Jean-Paul Beregi
发表日期
2006/12
期刊
Journal of Endovascular Therapy
卷号
13
期号
6
页码范围
701-710
出版商
SAGE Publications
简介
Purpose
To review clinical outcomes of patients with chronic limb ischemia and TASC type C lesions treated with sirolimus-eluting versus bare SMART nitinol self-expanding stents.
Methods
Data were obtained from a randomized, multicenter, double-blinded study conducted in 2 phases. All 93 patients had chronic limb ischemia and superficial femoral artery (SFA) occlusions or stenoses (average lesion length 8.3 cm). In total, 47 patients (31 men; mean age 66.3±9.1 years, range 50–84) received the sirolimus-eluting SMART stent and 46 patients (36 men; mean age 65.9 ± 10.8 years, range 38–83) received a bare SMART nitinol stent. Both groups were followed for a mean 24 months.
Results
Both the sirolimus-eluting and the bare SMART stents were effective in revascularizing the diseased SFA and in sustaining freedom from restenosis. For both types of stents, improvements in ankle-brachial indices (ABI) and …
引用总数
20072008200920102011201220132014201520162017201820192020202120222023202430474642443644554342383326251621217